Gene Query: MRPL51

Dataset Description Geneva Score
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 47.66
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 44.24
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 33.46
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 33.46
NRDE2 negatively regulates nuclear exosome functions 28.79
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 24.84
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 23.77
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 23.59
FOXD3 is a novel tumor suppressor in lung cancer 21.66
Genome wide expression change in LCC2 and MCF-7 cells 20.99
Role of microRNAs in the interaction between Salmonella and the host cell 19.83
RNA-Seq with and without RNase treatment in PCa cell lines 19.36
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 19.31
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 18.61
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 18.22
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.9
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 17.76
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 17.7
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 17.58
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 17.58
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 17.33
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 17.28
Identification of global regulators of T-helper cell lineage specification 17.28
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 17.15
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.4
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 16.15
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 15.91
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 15.67
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 15.6
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 15.47
Rorc disruption in human FG pancreatic cancer cells 15.15
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.98
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 14.9
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.87
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 14.49
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 14.46
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 14.39
Global analysis of enhancer targets: Mosaic-seq 14.38
Differentially expressed genes post knock down of lincDUSP26 13.77
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 13.55
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.26
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 13.22
Transcriptional profiles of normal human mature B cells 13.11
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 13.01
Effect of FGF13 depletion on the H460 cell line 12.93
Mitochondrial dsRNA triggers antiviral signalling in humans 12.81
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.69
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 12.6
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 12.6
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.43
Next generation sequencing of small RNAs isolated from exosomes in human semen 12.39
Widespread intronic polyadenylation diversifies immune cell transcriptomes 12.37
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 12.33
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.31
Identification of transcription start sites for human A549 cell line using ReCappable-seq 12.27
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 12.17
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 12.17
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 11.78
The comparison of high-throughput single-cell RNA-seq methods 11.77
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.67
CROP-Seq in Primary Human T Cells 11.55
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 11.52
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 11.52
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 11.38
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.33
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.25
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.24
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.2
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 11.19
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.16
TCF7L1 knockdown in pancreatic cancer 11.05
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 10.95
Effect of Influenza virus infection on lncRNA expression in A549 cells 10.81
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.71
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 10.58
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 10.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 10.51
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 10.51
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 10.45
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.18
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.08
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 10.05
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.04
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.03
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.84
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.82
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.81
RNAseq of HEK293 cells after Chtop knockdown 9.81
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.79
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 9.78
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 9.78
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 9.72
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 9.72
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.67
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 9.66
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 9.47
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 9.38
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 9.36
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.35
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.32
Transcriptome-wide response to synthetic chromatin protein PcTF 9.3
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 9.27
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 9.26
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 9.26
RNA-seq of resting and activated CD4+ T cells +-JQ1 9.17
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 9.14
Ribosomal footprinting of MDA-Parental and MDA-LM2 9.13
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 9.12
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 9.1
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.1
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 9.1
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 9.08
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 9.07
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 9.01
Effect of PRDM11 depletion in U2932 cells 9.01
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 8.98
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 8.96
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 8.92
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.86
Transcriptome analysis in Neobractatin treated cells 8.82
RNA sequencing of GlyH-101-treated MCF-7 cell line 8.82
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.81
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 8.77
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 8.75
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 8.72
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 8.72
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.67
Developmental stage specific chromosome architecture in human erythroid cells 8.67
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.54
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.54
RNA editing in nascent RNA affects pre-mRNA splicing 8.52
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.46
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.43
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 8.43
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 8.43
mRNA expression profile of Lymphocytes 8.43
Genome-wide functional assessment of enhancer activities in the human genome 8.42
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.4
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 8.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 8.39
Energy Metabolism during Anchorage-Independence 8.38
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 8.35
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 8.34
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.27
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.27
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 8.25
Differential gene expression of human melanoma cells [RNA-seq] 8.24
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 8.24
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 8.24
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.21
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 8.19
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.15
Regulatory network controlling tumor-promoting inflammation in human cancers 8.1
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 8.1
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 8.1
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 8.1
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 8.1
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.0
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.99
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.97
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.87
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.86
RNA sequencing of BT142 and TS603 cell lines 7.8
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 7.8
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 7.79
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.79
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.72
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 7.69
Gene expression changes after LOC550643 silencing 7.66
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.64
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 7.64
RNA-seq in transgenic cells 7.6
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 7.59
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.58
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.58
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.58
Transcriptomic analysis of the HOTAIR-regulated genes 7.57
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.53
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.45
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 7.42
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 7.4
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 7.38
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 7.38
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 7.33
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.31
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.27
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 7.27
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 7.27
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.24
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.2
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 7.19
Systematic discovery of endogenous human ribonucleoprotein complexes 7.19
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 7.18
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.12
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.07
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.07
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 7.06
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.03
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 7.02
RNA-sequencing of healthy human skeletal myocytes 7.01
hnRNP C is a key regulator of protein synthesis in mitosis 6.94
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 6.94
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.91
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.91
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 6.85
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.71
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.71
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.7
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.68
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.68
Transcriptomic analysis of human tonsillar TFH subsets 6.65
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 6.64
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.64
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.63
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.61
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.53
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.53
Iron response of HepG2 cells 6.52
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 6.5
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.48
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.47
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.44
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 6.44
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.43
Transcription control by the ENL YEATS domain in acute leukemia 6.43
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.42
Identification of renal resident macrophages across species 6.42
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.41
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 6.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 6.38
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.34
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.18
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.07
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.04
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.04
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.96
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 5.93
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.92
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.92
RNA-seq of RKO cells with cTAZ KO or putback 5.91
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.9
Human HAP1 cells before and after nutrient deprivation 5.9
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 5.88
RNA-seq data 5.87
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.82
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.81
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.81
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 5.79
HEK293 Heat-shock experiment 5.79
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 5.78
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.77
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.77
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 5.76
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.75
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.68
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 5.64
Dynamic 3D chromosomal landscapes in acute leukemia 5.64
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.59
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.59
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.59
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.58
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.57
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.57
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 5.54
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.54
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 5.53
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 5.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.5
RNA sequencing of primary human platelets and in vitro cell lines 5.45
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.44
DRB/GRO-Seq -/+ UV 5.41
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 5.41
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 5.3
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.28
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.28
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.19
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.14
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.1
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.1
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 5.06
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.01
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.98
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.9
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.8
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.73
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.72
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.7
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.67
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.65
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.65
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.64
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.64
Transcriptome analysis upon C6orf203 silencing 4.63
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.62
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.62
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.55
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.52
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.49
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.47
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.47
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.47
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.46
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.39
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 4.39
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.29
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.29
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 4.26
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 4.26
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 4.26
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 4.26
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 4.22
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 4.2
A20 regulates canonical wnt-signaling through an interaction with RIPK4 4.17
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.16
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.16
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.12
Genome-wide analysis of Dengue virus 2 infected cells 4.1
Transcriptome sequencing of K-562 cells 4.04
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.01
CDK4/6 inhibitor resistance in prostate cancer 4.01
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.97
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 3.97
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.96
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.94
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.94
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.91
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 3.88
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.85
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 3.84
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 3.76
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 3.76
Positively selected enhancer elements endow tumor cells with metastatic competence 3.73
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.72
Mapping interactions for the TNIP2 hub protein 3.71
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.66
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 3.64
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 3.64
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.55
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.49
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.49
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.41
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.4
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.35
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 3.33
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 3.29
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.27
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.25
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.22
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 3.21
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.2
Ribosome profiling upon inhibition of eIF4A 3.17
LIN28A Over-expression RNAseq 3.12
Unique features and clinical importance of acute alloreactive immune responses 3.09
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 3.02
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 3.02
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.0
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.0
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.94
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.9
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.8
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.79
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.79
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.79
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.77
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.76
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.73
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.72
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.72
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.7
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.68
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.68
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.66
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.61
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.6
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.57
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.55
Expression profiling of MCF-7 cells with treatment of TCDD 2.55
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.55
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.48
Determining mRNA half-lives on a transcriptome-wide scale 2.43
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.42
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 2.41
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.37
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.31
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.3
Copper Regulation of HIF-1 Transcription Activity 2.3
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.29
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.29
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.25
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.25
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.24
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 2.24
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.22
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.22
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.18
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.17
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.15
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.15
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.14
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.13
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.12
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.09
Gene expression profile in breast cancer cells 2.09
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.08
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.05
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 2.04
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.04
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.04
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.03
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.01
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.97
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.96
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.93
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.93
RNAseq of cell lines with knocked in ESR1 mutations 1.92
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.89
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.87
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.85
Exogenous rescue of KLHL9 in SF210 cell line 1.82
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 1.82
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.82
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.8
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.77
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.72
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.61
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.59
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.57
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.36
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.35
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.35
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.34
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.34
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.34
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.31
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.31
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.27
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.24
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.23
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.23
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 1.2
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.17
Single-cell analysis of human kidney organoids 1.13
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.13
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.13
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.13
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.13
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.12
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.1
Specific molecular signatures underlie response to decitabine in CMML 1.1
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.05
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.04
Global transcriptome analysis of WT versus HEB-/- hESCs 1.03
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.99
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.98
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.9
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.87
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.87
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.85
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.85
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.85
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.83
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.82
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.82
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.81
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.81
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.81
Dermal endothelial cells of type 2 diabetic patients 0.8
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.73
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.72
miR-93 Targets in Human Endothelial Cells 0.71
siRNA-mediated knockdown 0.7
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.65
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.57
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.54
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.46
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.46
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.44
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.4
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.38
Role of cervicovaginal microbiota in genital inflammation 0.37
SF3B1 Degron knockdown RNA-seq 0.37
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.35
Function and hormonal regulation of GATA3 in human first trimester placentation 0.35
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.32
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.15
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.12
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.07
O-glcnAc reprograms cellular energetics 0.06
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.05
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.04
Metastasis in triple-negative breast cancer 0.04
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.04
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation